Neutrophil-to-lymphocyte ratio, a predictor for mortality and unplanned hospital readmissions in patients aged 75 years and older with cancer.
Abstract
INTRODUCTION: Assessing the prognosis of older patients with cancer is essential to determine the best strategy for oncological care, given the heterogeneous profiles of this population. Evaluation should consider frailty, comorbidities, geriatric parameters, and oncological parameters. Finding early prognostic indicators would be helpful to optimize care. We aimed to investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients aged 75 and above with solid cancers. MATERIALS AND METHODS: Retrospective review of the ANCRAGE (ANalyse CanceR et sujet AGE) cohort that included all patients ≥75 years of age with solid cancer who were consecutively assessed in the geriatric oncology clinic of the University Hospital of Poitiers (France) between January 1, 2016 and August 31, 2023. Pretreatment assessment included socio-demographic data, oncological, clinical frailty scale (CFS) and geriatric assessment (GA). Geriatric domains assessed were level of dependence, risk of falls, nutrition, mood, and cognition. We defined frailty as the presence of at least one impairment in any of the geriatric domains. The NLR was determined within seven days before or after the GA and before any specific cancer treatment. Survival curves and Cox regression analyses were performed to assess the prognostic values in terms of overall survival (OS) and unplanned hospital readmissions (UHR). RESULTS: Overall, 1446 patients were included. Mean age was 86.6 years (± 5.2 years), with a male predominance (59 %). Most prevalent cancer sites were prostate (20 %, n = 283), colorectal (16 %, n = 230), breast (15 %, n = 217), skin (9 %, n = 134), and lung (7 %, n = 103), with metastatic status in over one-third of cases. The pretreatment GA identified frailty in 70 % of cases (n = 1012), with malnutrition (54 %, n = 774) and risk of falls (37 %, n = 538) being the main contributing factors. Median NLR was 3.50 [2.34-5.31]. There was a significant association between NLR and frailty using the CFS score (p < 0.001). The median follow-up time for OS analysis was 487 days [186-957]. The results of the multivariate analysis indicated that pretreatment NLR was an independent predictor of OS (hazard ratio [HR] 1.010, 95 % CI: 1.005-1.015, p < 0.001) and of UHR (HR 1.057, 95 % CI: 1.014-1.101, p = 0.008). Cut-off value >3.5 was associated with lower OS (p < 0.001). DISCUSSION: In our study, NLR was independently associated with higher mortality and high risk of unplanned hospital readmissions within one year of GA in older patients with solid tumors.
Related
- Pretreatment neutrophil-to-lymphocyte ratio is associated with clinical phenotypes and infection-related mortality in microscopic polyangiitis: the multicentre REVEAL cohort study
- Predicting unplanned readmissions in neurological patients: A large-scale AI-driven analysis using CHAID decision trees
- Inflammatory discordance phenotype in COPD: Dissociation between neutrophil-to-lymphocyte ratio and conventional markers
- Combination of Clinical Frailty Score and Myostatin Concentrations as Mortality Predictor in Hemodialysis Patients
- Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality
BibTeX
@article{barcaglioni2026neutrophiltolymphocyte,
title = {{Neutrophil-to-lymphocyte ratio, a predictor for mortality and unplanned hospital readmissions in patients aged 75 years and older with cancer.}},
author = {Giorgia Ceci Barcaglioni and Julie Tisserand and Simon Valero and Patrick Bouchaert and Mélanie Bouisset and Emilie Favard and Yvan Moreno and Oriane Chauvineau and Florent Seite and Marc Paccalin and Evelyne Liuu},
journal = {Journal of Geriatric Oncology},
year = {2026},
month = oct,
doi = {10.1016/j.jgo.2025.102316},
url = {https://hal.science/hal-05773720v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Neutrophil-to-lymphocyte ratio, a predictor for mortality and unplanned hospital readmissions in patients aged 75 years and older with cancer.
AU - Giorgia Ceci Barcaglioni
AU - Julie Tisserand
AU - Simon Valero
AU - Patrick Bouchaert
AU - Mélanie Bouisset
AU - Emilie Favard
AU - Yvan Moreno
AU - Oriane Chauvineau
AU - Florent Seite
AU - Marc Paccalin
AU - Evelyne Liuu
PY - 2026
DA - 2026/10/01
JO - Journal of Geriatric Oncology
DO - 10.1016/j.jgo.2025.102316
UR - https://hal.science/hal-05773720v1
AB - INTRODUCTION: Assessing the prognosis of older patients with cancer is essential to determine the best strategy for oncological care, given the heterogeneous profiles of this population. Evaluation should consider frailty, comorbidities, geriatric parameters, and oncological parameters. Finding early prognostic indicators would be helpful to optimize care. We aimed to investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients aged 75 and above with solid cancers. MATERIALS AND METHODS: Retrospective review of the ANCRAGE (ANalyse CanceR et sujet AGE) cohort that included all patients ≥75 years of age with solid cancer who were consecutively assessed in the geriatric oncology clinic of the University Hospital of Poitiers (France) between January 1, 2016 and August 31, 2023. Pretreatment assessment included socio-demographic data, oncological, clinical frailty scale (CFS) and geriatric assessment (GA). Geriatric domains assessed were level of dependence, risk of falls, nutrition, mood, and cognition. We defined frailty as the presence of at least one impairment in any of the geriatric domains. The NLR was determined within seven days before or after the GA and before any specific cancer treatment. Survival curves and Cox regression analyses were performed to assess the prognostic values in terms of overall survival (OS) and unplanned hospital readmissions (UHR). RESULTS: Overall, 1446 patients were included. Mean age was 86.6 years (± 5.2 years), with a male predominance (59 %). Most prevalent cancer sites were prostate (20 %, n = 283), colorectal (16 %, n = 230), breast (15 %, n = 217), skin (9 %, n = 134), and lung (7 %, n = 103), with metastatic status in over one-third of cases. The pretreatment GA identified frailty in 70 % of cases (n = 1012), with malnutrition (54 %, n = 774) and risk of falls (37 %, n = 538) being the main contributing factors. Median NLR was 3.50 [2.34-5.31]. There was a significant association between NLR and frailty using the CFS score (p < 0.001). The median follow-up time for OS analysis was 487 days [186-957]. The results of the multivariate analysis indicated that pretreatment NLR was an independent predictor of OS (hazard ratio [HR] 1.010, 95 % CI: 1.005-1.015, p < 0.001) and of UHR (HR 1.057, 95 % CI: 1.014-1.101, p = 0.008). Cut-off value >3.5 was associated with lower OS (p < 0.001). DISCUSSION: In our study, NLR was independently associated with higher mortality and high risk of unplanned hospital readmissions within one year of GA in older patients with solid tumors.
SN - 1879-4068
SN - 1879-4076
ER -